Allogeneic Cell Therapy Devices Market
According to Intent Market Research, the Allogeneic Cell Therapy Devices Market is expected to grow from USD 0.5 billion in 2023 at a CAGR of 22.3% to touch USD 1.9 billion by 2030. The Allogeneic Cell Therapy Devices Market is dominated by key players such as Thermo Fisher Scientific, Lonza Group, Merck KGaA, Sartorius AG, Corning Incorporated, Cytiva (Danaher Corporation), Terumo Corporation, Eppendorf AG, Bio-Techne Corporation, Miltenyi Biotec, STEMCELL Technologies, Fujifilm Irvine Scientific, CellGenix GmbH, Beckman Coulter (Danaher Corporation), Bluebird Bio, Inc.